Pre-market · Oct 8, 7:30 am ET · After hours $4.62 0.00%
Open$4.58
Prev close$4.61
Day range$4.53 – $4.67
Volume1.36M
Market cap$579.86M
P/E (TTM)–
Dividend yield–
AQST Stock News
Headlines matching Aquestive Therapeutics or the AQST ticker, most recent first.
H.C. Wainwright Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $10Market news · 22 Sep 2026 · Direct mention
Lake Street Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $6Market news · 17 Sep 2026 · Direct mention
LifeSci Capital Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $10Market news · 17 Sep 2026 · Direct mention
LifeSci Capital Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Raises Target Price to $10PositiveMarket news · 11 Aug 2026 · Direct mention
Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Aquestive Therapeutics (AQST) and Alto Neuroscience, Inc. (ANRO)TipRanks · 26 Jun 2026 · Direct mention
LifeSci Capital Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $9Market news · 26 Jun 2026 · Direct mention
Cantor Fitzgerald Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $11Market news · 26 Jun 2026 · Direct mention
Oppenheimer Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $8Market news · 25 Jun 2026 · Direct mention
A Quick Look at Today's Ratings for Aquestive Therapeutics(AQST.US), With a Forecast Between $6 to $9Market news · 16 May 2026 · Direct mention
A. G. P. Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $9Market news · 15 May 2026 · Direct mention
Analysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST) and Ardent Health Partners, Inc. (ARDT)TipRanks · 15 May 2026 · Direct mention
Piper Sandler Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $8Market news · 15 May 2026 · Direct mention
Oppenheimer Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Announces Target Price $8Market news · 9 Mar 2026 · Direct mention
A. G. P. Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Cuts Target Price to $9NegativeMarket news · 6 Mar 2026 · Direct mention
Leerink Partners Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Announces Target Price $9Market news · 6 Mar 2026 · Direct mention
Discussion
No comments yet — be the first to weigh in on AQST.
No comments yet — be the first to weigh in on AQST.